Season 2: episode 8
In this episode, GOLD speaks to Magnus Björsne, CEO, AstraZeneca BioVentureHub, about the impact of the pandemic on innovation, collaboration and creativity within the industry. He discusses the importance of not returning to old ways of working, the key pillars of healthcare ecosystems of the future and his favourite innovations of recent times.
This episode also features a special diabetes-focused ‘Things you might have missed’, with news on novel management and monitoring technology for people living with diabetes.
A little more on GOLD’s guest…
Magnus Björsne has worked at AstraZeneca for 22 years and has been a leading figure in the field of business development since 2006. In 2014, he became CEO of an innovation hub in AstraZeneca’s A.Catalyst Network called BioVentureHub, an initiative at their Gothenburg campus that allows smaller biotechs and academic groups to work alongside the minds of AstraZeneca. Björsne is an innovation architect and business development leader with a passion for creating innovative solutions for the pharmaceutical industry and wider healthcare systems.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Click here to subscribe to the weekly newsletter for more insights from GOLD.